Edo retweeted
$grvy
- **Total Enterprise Value (TEV)**: KRW 4,488.12 billion
- **Cash and Equivalents**: KRW 112.75 billion
- **Debt**: KRW 0 billion
- **Equity Value**: KRW 4,600.87 billion
- **Shares Outstanding**: 7 million
**Intrinsic Stock Price**: Approximately **KRW 657,267** per share
$biovic
My key takeaway from yesterday’s press release call regarding Q2 Interim report for Biovica :
1.Million dollar question - pending FDA approval. FDA had ambitions giving feedback during November but this has been delayed and will hopefully be deliver during December
Q2 Interim report - Promising results published at ESMO loom.ly/0WRtnhc
Live audiocast 1st of December 2021 at 15:00 CET loom.ly/M0HSryM
#Biovica #DiviTum #treatmentswithgreaterconfidence #breastcancer
The delay of FDA has not had an impact on the company’s capital needs and no impairment loss on capitalized development cost of DiviTum.
1
Link to the press release. Recommend to listen and form your own opinion and not just take my words for it..
tv.streamfabriken.com/biovic…